RIVAROXABAN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62332-683 -
Package NDC
62332-683-10 -
Package NDC
62332-683-45 -
Package NDC
62332-683-60 -
Package NDC
62332-683-91 -
Application number
ANDA210301 -
SPL ID
30e909dc-eab4-4caf-831d-d46d4921b9ce -
SPL set ID
e62f23c6-89f2-4179-95dc-5732401b3f93 -
UNII
9NDF7JZ4M3 -
RxCUI
1114198 -
RxCUI
1232082 -
RxCUI
1232086 -
RxCUI
1549682 -
RxCUI
2059015
What the source publishes
- Labeler
- Alembic Pharmaceuticals Inc.
- Active ingredients
- RIVAROXABAN
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "RIVAROXABAN",
"splId": "30e909dc-eab4-4caf-831d-d46d4921b9ce",
"labels": [
{
"setId": "e62f23c6-89f2-4179-95dc-5732401b3f93",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e62f23c6-89f2-4179-95dc-5732401b3f93",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e62f23c6-89f2-4179-95dc-5732401b3f93"
}
],
"routes": [
"ORAL"
],
"labeler": "Alembic Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 BLISTER PACK in 1 CARTON (62332-683-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK",
"package_ndc": "62332-683-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
},
{
"sample": false,
"description": "180 TABLET, FILM COATED in 1 BOTTLE (62332-683-45)",
"package_ndc": "62332-683-45",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (62332-683-60)",
"package_ndc": "62332-683-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
},
{
"sample": false,
"description": "1000 TABLET, FILM COATED in 1 BOTTLE (62332-683-91)",
"package_ndc": "62332-683-91",
"identifierStatus": "well-formed",
"marketing_start_date": "20250514"
}
],
"productId": "62332-683_30e909dc-eab4-4caf-831d-d46d4921b9ce",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "62332-683",
"deaSchedule": null,
"genericName": "RIVAROXABAN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIVAROXABAN",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA210301",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250514",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175635",
"N0000175637"
],
"upc": [
"0362332347308",
"0362332348305",
"0362332683604",
"0362332346301"
],
"unii": [
"9NDF7JZ4M3"
],
"rxcui": [
"1114198",
"1232082",
"1232086",
"1549682",
"2059015"
],
"spl_set_id": [
"e62f23c6-89f2-4179-95dc-5732401b3f93"
],
"pharm_class_epc": [
"Factor Xa Inhibitor [EPC]"
],
"pharm_class_moa": [
"Factor Xa Inhibitors [MoA]"
],
"manufacturer_name": [
"Alembic Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62332-683_30e909dc-eab4-4caf-831d-d46d4921b9ce"